Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gates

Showing results (191-200 of 234) with videos related to

Pageof 24
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|November 16, 2007
Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinomaJoseph Y Young, Thomas K Rhee, Bassel Atassi, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 4, 2016
Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular CarcinomaRyan Hickey, Samdeep Mouli, Laura Kulik, et al.
Radiology|October 9, 2008
MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility studyTwinkle Gupta, Sumeet Virmani, Tod M Neidt, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 12, 2014
Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolizationKhairuddin Memon, Laura M Kulik, Robert J Lewandowski, et al.
Journal of Hepatology|March 8, 2020
Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating lung shunt estimationAhmed Gabr, Srirajkumar Ranganathan, Samdeep K Mouli, et al.
Hepatology (Baltimore, Md.)|November 22, 2007
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosisLaura M Kulik, Brian I Carr, Mary F Mulcahy, et al.
Academic Radiology|June 12, 2020
Yttrium-90 Radioembolization and Tumor Hypoxia: Gas-challenge BOLD Imaging in the VX2 Rabbit Model of Hepatocellular CarcinomaAndrew C Gordon, Sarah B White, Vanessa L Gates, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 9, 2005
Angiographic considerations in patients undergoing liver-directed therapyDavid M Liu, Riad Salem, James T Bui, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 15, 2007
90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survivalAffaan K Bangash, Bassel Atassi, Virginia Kaklamani, et al.
Journal of General Internal Medicine|April 26, 2022
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort StudyEn-Ling Wu, Rebecca N Kumar, W Justin Moore, et al.
Pageof 24

Showing results (191-200 of 234) with videos related to

Sort By:
Pageof 24
Journal of Vascular and Interventional Radiology : JVIR|November 16, 2007
Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinomaJoseph Y Young, Thomas K Rhee, Bassel Atassi, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 4, 2016
Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular CarcinomaRyan Hickey, Samdeep Mouli, Laura Kulik, et al.
Radiology|October 9, 2008
MR tracking of iron-labeled glass radioembolization microspheres during transcatheter delivery to rabbit VX2 liver tumors: feasibility studyTwinkle Gupta, Sumeet Virmani, Tod M Neidt, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 12, 2014
Comparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolizationKhairuddin Memon, Laura M Kulik, Robert J Lewandowski, et al.
Journal of Hepatology|March 8, 2020
Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating lung shunt estimationAhmed Gabr, Srirajkumar Ranganathan, Samdeep K Mouli, et al.
Hepatology (Baltimore, Md.)|November 22, 2007
Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosisLaura M Kulik, Brian I Carr, Mary F Mulcahy, et al.
Academic Radiology|June 12, 2020
Yttrium-90 Radioembolization and Tumor Hypoxia: Gas-challenge BOLD Imaging in the VX2 Rabbit Model of Hepatocellular CarcinomaAndrew C Gordon, Sarah B White, Vanessa L Gates, et al.
Journal of Vascular and Interventional Radiology : JVIR|July 9, 2005
Angiographic considerations in patients undergoing liver-directed therapyDavid M Liu, Riad Salem, James T Bui, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 15, 2007
90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survivalAffaan K Bangash, Bassel Atassi, Virginia Kaklamani, et al.
Journal of General Internal Medicine|April 26, 2022
Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort StudyEn-Ling Wu, Rebecca N Kumar, W Justin Moore, et al.
Pageof 24